南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

翌圣生物 Yeasen|生命科学试剂与诊断原料一站式平台

Dental pulp mesenchymal stem cell-derived exosomes alleviate intervertebral disc degeneration by inhibition of macrophage M1 polarization

Peihong Hou, Yuhui Cui, Youwei Jiang, Liang Wang, Wenchao Wang, Yawei Yao, Jingjing Huang, Zhihao Ma, Dingmeng Hu, Wenhao Hu, Hua Wang, Xuesong Zhang

Journal:Nano Today

IF:10.7

DOI:10.1016/j.nantod.2026.103123

PMID:

Published:2026-07-13

research field:

Abstract

Exosomes derived from dental pulp stem cells (DPSCs-Exos) possess potent immunomodulatory properties, but their therapeutic efficacy and underlying mechanisms in intervertebral disc degeneration (IVDD) remain unexplored. Here, we demonstrate that DPSCs-Exos effectively mitigate IVDD through modulation of macrophage polarization, as evidenced by both in vitro and in vivo experiments. Mechanistically, RNA sequencing identified the ERK/MAPK signaling pathway as a key mediator, a finding further validated using the specific ERK inhibitor PD98059. Our results reveal that DPSCs-Exos suppress M1 macrophage polarization and reduce pro-inflammatory cytokine secretion via inhibition of the ERK/MAPK pathway, thereby preserving nucleus pulposus cell function and maintaining extracellular matrix homeostasis. Collectively, this study uncovers a novel regulatory mechanism by which DPSCs-Exos alleviate IVDD and positions them as a promising cell-free therapeutic strategy for treating this debilitating condition.

本文使用的Yeasen产品

购物车
客服
转染试用